Close

Galena Biopharma (GALE) Discloses SEC Investigation

March 17, 2014 5:13 PM EDT Send to a Friend
In its 10-K Galena Biopharma, Inc. (NASDAQ: GALE) discloses an SEC investigation related to an outside investor-relations firm

From ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login